XXICEXXSUPXXY DXXISIXX — Vaccine Importer Profile
Pharmaceutical Importer · #9 buyer for Vaccine · $1.9M import value · 48 shipments · CHAD · DGFT Verified
XXICEXXSUPXXY DXXISIXX is the #9 importer of Vaccine from India with $1.9M in import value and 48 verified shipments. XXICEXXSUPXXY DXXISIXX holds a 0.3% market share in Vaccine imports based in CHAD. The company sources from 1 verified supplier across 11 formulations shipped to 23 countries.
XXICEXXSUPXXY DXXISIXX — Vaccine Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Vaccine to XXICEXXSUPXXY DXXISIXX?
Verified from 48 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| SERUM INSTITUTE OF INDIA PRIVATE LIMITED | $1.9M | 48 | 100.0% |
XXICEXXSUPXXY DXXISIXX sources Vaccine from 1 verified Indian supplier based on 48 customs records. The primary supplier is SERUM INSTITUTE OF INDIA PRIVATE LIMITED accounting for 100.0% of imports.
How Does XXICEXXSUPXXY DXXISIXX Compare to Nearest Vaccine Importers?
Buyers ranked immediately above and below #9 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | D.G. CENTRAL MEDICAL STORES DEPT | BANGLADESH | $2.7M | 54 | $50.0K |
| 5 | EXPANDED PROGRAM ON IMMUNIZATION | PAKISTAN | $2.4M | 48 | $50.0K |
| 9 | XXICEXXSUPXXY DXXISIXX ★ | AFGHANISTAN | $2.4M | 48 | $50.0K |
| 11 | EXPANDED PROGRAMME ON IMMUNIZATION | PAKISTAN | $2.3M | 45 | $50.0K |
| 13 | CENTURION ILAC SANAYI VE TICARET AN | TURKEY | $2.1M | 42 | $50.0K |
XXICEXXSUPXXY DXXISIXX ranks #9 among 2,202 Vaccine importers from India. Average shipment value of $50.0K compared to the market average of $17.3K. The closest competitors by value are D.G. CENTRAL MEDICAL STORES DEPT and EXPANDED PROGRAM ON IMMUNIZATION.
Where Does XXICEXXSUPXXY DXXISIXX Import Vaccine To?
Destination countries from 48 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CHAD | $300.0K | 6 | 15.4% |
| AFGHANISTAN | $250.0K | 5 | 12.9% |
| PHILIPPINES | $150.0K | 3 | 7.7% |
| FIJI | $139.3K | 6 | 7.2% |
| CONGO (KINSHASA) | $114.7K | 3 | 5.9% |
| TAJIKISTAN | $100.0K | 2 | 5.1% |
| UGANDA | $100.0K | 2 | 5.1% |
| SUDAN | $100.0K | 2 | 5.1% |
| TURKEY | $100.0K | 2 | 5.1% |
| YEMEN | $94.5K | 3 | 4.9% |
XXICEXXSUPXXY DXXISIXX imports Vaccine to 23 countries. The primary destination is CHAD receiving 15.4% of shipments worth $300.0K.
What Vaccine Formulations Does XXICEXXSUPXXY DXXISIXX Import?
| Formulation | Value | Shipments |
|---|---|---|
| OTHER SINGLE VACCINE-VIRAL VACCINE- | $450.0K | 9 |
| SINGLE VACCINES FOR TB- | $423.9K | 12 |
| OTHER MIX VACCINE-VIRAL VACCINE- | $217.5K | 5 |
| VACCINE FOR POLIO-POLIOMYELITIS- | $200.0K | 4 |
| MIXED VACCINE FOR MMR-VIRAL VACCINE- | $196.3K | 6 |
| VACCINE FOR HUMAN MEDICINE- | $155.4K | 5 |
| OTHER SINGLE VACCINE-MEN- | $150.0K | 3 |
| MIXED VACCINE FOR MMR-VIRAL VACCINE- (INV) | $50.0K | 1 |
| VACCINE FOR POLIO-POLIOMYELITIS- (INV) | $50.0K | 1 |
| OTHER SINGLE VACCINE-VIRAL VACCINE- (INV) | $35.4K | 1 |
XXICEXXSUPXXY DXXISIXX imports 11 distinct Vaccine formulations from India. The top formulation is OTHER SINGLE VACCINE-VIRAL VACCINE- with 9 shipments worth $450.0K.
Who Are the Top Buyers of Vaccine from India and How Much Does XXICEXXSUPXXY DXXISIXX Import?
India exported $38.1M worth of Vaccine through 14,355 shipments from 325 suppliers to 192 countries, serving 2,202 buyers globally. XXICEXXSUPXXY DXXISIXX imports $1.9M of this total, accounting for 0.3% of India's Vaccine exports with 48 shipments from CHAD. This is verified from 48 customs shipment records covering 11 distinct formulations.
What Is the Average Order Value for XXICEXXSUPXXY DXXISIXX's Vaccine Imports?
XXICEXXSUPXXY DXXISIXX's average Vaccine order value is $40.5K per consignment, based on 48 shipments totaling $1.9M. XXICEXXSUPXXY DXXISIXX is based in CHAD and ranks #9 among all Vaccine importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Vaccine to XXICEXXSUPXXY DXXISIXX?
XXICEXXSUPXXY DXXISIXX sources Vaccine from 1 verified Indian supplier: SERUM INSTITUTE OF INDIA PRIVATE LIMITED ($1.9M, 100.0%). This is based on 48 customs records.
How Does XXICEXXSUPXXY DXXISIXX Compare to Other Vaccine Importers?
XXICEXXSUPXXY DXXISIXX ranks #9 among 2,202 Vaccine importers from India with a 0.3% market share. The top 3 importers are NATIONAL PRIMARY HEALTH CARE ($6.3M), UNICEF SUPPLY DIVISION ($5.0M), MINISTRY OF HEALTH ($4.5M). XXICEXXSUPXXY DXXISIXX processed 48 shipments from CHAD.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vaccine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vaccine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: XXICEXXSUPXXY DXXISIXX matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as XXICEXXSUPXXY DXXISIXX's capped import value divided by total capped export value for Vaccine across all Indian exporters.
- 5.Verified Records: This page is backed by 48 individual customs records matching XXICEXXSUPXXY DXXISIXX importing Vaccine, covering 11 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 192+ countries, 2,202+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vaccine Import Data for XXICEXXSUPXXY DXXISIXX
Access order-level details, pricing data, supplier connections, and competitive analysis for XXICEXXSUPXXY DXXISIXX's Vaccine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
XXICEXXSUPXXY DXXISIXX
Company Profile
Multiple products · $0 total trade · Multiple categories
XXICEXXSUPXXY DXXISIXX × Vaccine
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for XXICEXXSUPXXY DXXISIXX.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vaccine. For current order-level data, contact TransData Nexus.